Sponsor content
192 result(s) found, displaying 31 to 40
-
Cancellation by sponsorRequested by Eli Lilly Australia Pty Ltd
-
Apr-2025Prescription medicine evaluationActive ingredient: imlunestrant tosilate.
-
Mar-2025Prescription medicine evaluationActive ingredient: pirtobrutinib.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TALTZ ixekizumab 80 mg/mL solution for injection prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TALTZ ixekizumab 80 mg/mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO KwikPen tirzepatide 20.83 mg/mL solution for injection multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO KwikPen tirzepatide 25 mg/mL solution for injection multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO KwikPen tirzepatide 8.33 mg/mL solution for injection multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO KwikPen tirzepatide 4.17 mg/mL solution for injection multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO KwikPen tirzepatide 16.67 mg/mL solution for injection multidose pre-filled pen.